Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 25

Trial Status

Completed4
Terminated1

Role Distribution

Principal Investigator1
Other Roles4
PI Rate20%

Activity Timeline

Clinical Trials (5)

NCT00772915Phase 2Completed
Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
StudychairStart date: 2008-12-03
NCT00474929Phase 1/2Completed
Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
PrincipalinvestigatorStart date: 2007-08-29
NCT00635024Phase 2Terminated
Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Studychair

Research Network

Collaboration Network

13 collaborators·14 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Mayo Clinic

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jorge Cortes, MD

M.D. Anderson Cancer Center

Moderately Similar
24 trials

Shared therapeutic areas:

LymphomaMultiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Charles L. Loprinzi, MD

Mayo Clinic

Moderately Similar
14 trials

Shared therapeutic areas:

LymphomaMultiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Similarity Score30%

Steven R. Alberts, MD

Mayo Clinic

Moderately Similar
14 trials

Shared therapeutic areas:

LymphomaMultiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Thomas E. Witzig, MD

Mayo Clinic

Related
12 trials

Shared therapeutic areas:

LymphomaMultiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)+1 more
Collaborated on 1 trial
Similarity Score24%

Craig B. Reeder, MD

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Collaborated on 2 trials
Similarity Score18%

Vincenzo Liso, MD

UO Universita degi Studi Policinico Ematologia

Related
1 trials

Shared therapeutic areas:

Lymphoma
Similarity Score15%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Wendy Stock, MD

University of Chicago Hospital

Related
1 trials

Shared therapeutic areas:

Lymphoma
Similarity Score15%

Vernon Louw, MD

Free State University

Related
1 trials

Shared therapeutic areas:

Lymphoma
Similarity Score15%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT00772915Phase 2StudyChair

Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
Completed
NCT00474929Phase 1/2PrincipalInvestigator

Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Completed
NCT00478218Phase 2StudyChair

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
Completed
NCT00564889Phase 2StudyChair

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Multiple Myeloma and Plasma Cell Neoplasm
Completed
NCT00635024Phase 2StudyChair

Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
Terminated

All 5 trials loaded